Department of Dermatopathology, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Breast Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
J Cutan Pathol. 2021 Nov;48(11):1387-1391. doi: 10.1111/cup.14080. Epub 2021 Jun 16.
Syringocystadenocarcinoma papilliferum (SCACP) is a rare cutaneous adnexal tumor thought to originate from its benign counterpart, syringocystadenoma papilliferum. These tumors are predominantly located on the head and neck with their location on the breast extraordinarily reported; mammary localization poses a great diagnostic dilemma to the practicing pathologist. Herein, we report an unusual case of an 85-year-old woman with an outside diagnosis on a core needle biopsy of metaplastic mammary carcinoma. Upon consultative review of the partial mastectomy specimen, SCACP was identified. Herein, we review SCACP and the diagnostic challenge it poses, especially when localized to the breast. Furthermore, we perform a retrospective review of institutional pathology reports and identified four additional cases of SCACP diagnosed at our institution within the last decade. Finally, we briefly review the literature of SCACP. The entity of SCACP should be well known to pathologists to avoid misdiagnosis.
汗管囊腺癌(SCACP)是一种罕见的皮肤附属器肿瘤,被认为起源于其良性 counterpart,即汗管囊腺瘤。这些肿瘤主要位于头部和颈部,其在乳房上的位置极为罕见;乳房定位给临床病理学家带来了极大的诊断难题。在此,我们报告了一例 85 岁女性的罕见病例,其在核心针活检中被诊断为间变性乳腺癌。在对部分乳房切除术标本进行会诊后,发现了 SCACP。在此,我们回顾了 SCACP 及其带来的诊断挑战,特别是当它位于乳房时。此外,我们对机构病理学报告进行了回顾性分析,发现了过去十年内在我们机构诊断的另外 4 例 SCACP 病例。最后,我们简要回顾了 SCACP 的文献。病理学家应该非常了解 SCACP 的实体,以避免误诊。